157 related articles for article (PubMed ID: 26848142)
1. Dual time-point (18)F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases.
Lafuente S; Fuster D; Arguis P; Granados U; Perlaza P; Paredes P; Vollmer I; Sánchez M; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):226-31. PubMed ID: 26848142
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
[TBL] [Abstract][Full Text] [Related]
4. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
[TBL] [Abstract][Full Text] [Related]
5. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Chen S; Li X; Chen M; Yin Y; Li N; Li Y
Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
[TBL] [Abstract][Full Text] [Related]
6. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
[TBL] [Abstract][Full Text] [Related]
7. Increase in fluorodeoxyglucose positron emission tomography activity following complete radiofrequency ablation of lung tumors.
Sharma A; Lanuti M; He W; Palmer EL; Shepard JA; Digumarthy SR
J Comput Assist Tomogr; 2013; 37(1):9-14. PubMed ID: 23321827
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.
Bonichon F; Palussière J; Godbert Y; Pulido M; Descat E; Devillers A; Meunier C; Leboulleux S; de Baère T; Galy-Lacour C; Lagoarde-Segot L; Cazeau AL
Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1817-27. PubMed ID: 24042540
[TBL] [Abstract][Full Text] [Related]
9. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of dual-time
Pahk K; Chung JH; Kim S; Lee SH
Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
[TBL] [Abstract][Full Text] [Related]
11. Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.
Suzawa N; Yamakado K; Takao M; Taguchi O; Yamada T; Takeda K
Clin Nucl Med; 2013 Apr; 38(4):e166-70. PubMed ID: 23429399
[TBL] [Abstract][Full Text] [Related]
12. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
[TBL] [Abstract][Full Text] [Related]
13. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.
Deandreis D; Leboulleux S; Dromain C; Auperin A; Coulot J; Lumbroso J; Deschamps F; Rao P; Schlumberger M; de Baère T
Radiology; 2011 Jan; 258(1):270-6. PubMed ID: 21045185
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
Yoo DC; Dupuy DE; Hillman SL; Fernando HC; Rilling WS; Shepard JA; Siegel BA
AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation of lung metastases from colorectal carcinoma under C-arm cone beam CT guidance.
Amouyal G; Pernot S; Déan C; Cholley B; Scotté F; Sapoval M; Pellerin O
Diagn Interv Imaging; 2017 Nov; 98(11):793-799. PubMed ID: 28571704
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic yield of baseline and follow-up PET/CT studies in ablative therapy for non-small cell lung cancer.
Pou Ucha JL; Nogueiras Alonso JM; Alvarez Paez AM; Suarez Arfenoni BA; Puig AS; Lopez Lopez AM; Barandela Salgado J; Campos Villarino LM; Casal Rivas M; Guitian Iglesias R
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):301-7. PubMed ID: 23084012
[TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer.
Wang Y; Lanuti M; Bernheim A; Shepard JO; Sharma A
Int J Hyperthermia; 2018; 35(1):1-8. PubMed ID: 29719997
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET.
Higuchi M; Honjo H; Shigihara T; Shishido F; Suzuki H; Gotoh M
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1957-63. PubMed ID: 24952227
[TBL] [Abstract][Full Text] [Related]
19. Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
Liu ZY; Chang ZH; Lu ZM; Guo QY
Chin Med J (Engl); 2010 Jul; 123(13):1690-4. PubMed ID: 20819630
[TBL] [Abstract][Full Text] [Related]
20. Single-session radiofrequency ablation of bilateral lung metastases.
Palussière J; Gómez F; Cannella M; Ferron S; Descat E; Fonck M; Brouste V; Avril A
Cardiovasc Intervent Radiol; 2012 Aug; 35(4):852-9. PubMed ID: 21647807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
